Anc80 AAV Detection Kits for Early Purification Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Purification of adeno-associated viruses (AAVs) is a time-consuming and labor-intensive process, with low yield batches often undetected until significant time and resources have been invested, leading to increased costs and reduced production efficiency.
Innovation Solution
A method and kit for detecting adeno-associated virus serotype Anc80 using capture and detection reagents, such as antibodies, immobilized on a surface, allowing for rapid and specific detection during the purification process, even in crude samples, using HPLC and ELISA techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional purification methods are used, then purification can be performed, but the process is time-consuming and labor-intensive
Solution Approach 1:
The invention performs detection of AAV titer and quality parameters before completing the full purification process. By implementing detection early in the workflow (even in crude lysates), the system identifies low-yield batches beforehand, preventing waste of time and resources on subsequent purification steps for failed batches.
Solution Approach 2:
The invention extracts the detection function from the purification process itself, allowing independent assessment of AAV quality. This separation enables detection to occur at any stage, including before purification is complete, thereby resolving the contradiction between purification speed and detection timing.
2Measurement precision
If detection is performed after purification, then accurate titer measurement is achieved, but low yield batches are not detected until substantial time and resources are spent
Solution Approach 1:
The detection method is designed to work with crude lysates and partially purified samples, enabling titer measurement and quality assessment before purification is complete. This preliminary detection identifies low-yield batches early, preventing waste of substantial time and resources while maintaining measurement precision through validated detection protocols.
Solution Approach 2:
The invention segments the detection process into stages that can occur at different points in the purification workflow. Detection can be performed on crude lysates, partially purified samples, or final products, allowing flexible timing that enables early identification of failed batches while maintaining measurement accuracy.
3Measurement precision
If multiple serotype-specific reagents are used, then specific detection is achieved, but the process becomes complex and less efficient
Solution Approach 1:
The invention employs a universal detection approach using anti-capsid antibodies that can detect multiple AAV serotypes (AAV1, AAV2, AAV5, AAV8, AAV9, and Anc80) with a single reagent system. This multi-functional detection method maintains serotype identification capability while eliminating the need for multiple serotype-specific reagents, thereby reducing complexity.
Solution Approach 2:
The invention merges the detection capability for multiple serotypes into a single assay system. By using antibodies that recognize conserved epitopes across serotypes or by implementing a detection panel that can identify different serotypes simultaneously, the system combines multiple detection functions into one unified process, reducing reagent variety and procedural complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient and sensitive detection of Anc80 during AAV production, reducing time and costs by identifying low yield batches early, and simplifying the purification process.
Implementation Method 1
contacting the sample with: (i) a capture reagent that specifically binds an adeno-associated virus (AAVx) or an adeno-associated virus serotype 8 (AAV8)
Implementation Method 2
a detection reagent that binds a broad array of adeno-associated virus serotypes (AAVx)
Implementation Method 3
subjecting the cell lysate to gradient purification (e.g., using a iodixanol gradient) and/or fast protein liquid chromatography (FPLC), which can be ion exchange, size exclusion, and/or affinity based
Implementation Method 4
Detection methods include HPLC- and ELISA-based methods
Data Source
Figure 1
Figure 2A~2B
Figure 2C
AI summary
The present disclosure provides methods and kits for detecting adeno-associated viruses. In some embodiments, the adeno-associated virus is Anc80. Detection methods include HPLC- and ELISA-based methods.